← Back to headlines
BioMérieux Stock Falls After Lowered 2026 Forecasts
Shares of BioMérieux, a medical test specialist, dropped significantly on the Paris Bourse after the company lowered its financial forecasts for 2026 following a decline in first-quarter results.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
